Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
Slika profila

Stjepko Pleština

13329

Stjepko

Pleština

dr. sc.

Naziv Uloga Akcije
Molekularni biljezi u solidnim tumorima - prediktivni i prognostički značaj voditelj
Biomedicinsko oslikavanje karcinoma dojke suradnik
Naziv Akcije
Budisavljević, Anuška ; Kelemenić-Dražin, Renata ; Silovski, Tajana ; Stjepko, Pleština ; Dedić Plavetić, Natalija Correlation between psychological resilience and burnout syndrome in oncologists amid the Covid-19 pandemic // Supportive care in cancer, Volume 31 (2023), Issue 4; 207, 9. doi: 10.1007/s00520-023-07660-3
Bišof, Vesna ; Soče, Maja ; Vidović, Marina ; Viculin, Jelena ; Vrdoljak, Eduard ; Pleština, Stjepko REAL WORLD SURVIVAL OUTCOMES IN ADVANCED GASTRIC AND ESOPHAGOGASTRIC ADENOCARCINOMA – A RETROSPECTIVE ANALYSIS FROM UNIVERSITY HOSPITAL CENTRES ZAGREB AND SPLIT // Libri oncologici : Croatian journal of oncology, 51, 1. 2023. str. 78-79
Prejac, Juraj; Omrčen, Tomislav; Radić, Jasna; Vrdoljak, Eduard; Frobe, Ana; Pleština, Stjepko Predicting Trifluridine/Tipiracil Treatment in Refractory Metastatic Colorectal Cancer Patients: A Multicenter Exploratory Analysis // Oncology, (2023), doi: 10.1159/000533567
Golčić, Marin ; Simetić, Luka ; Herceg, Davorin ; Blažičević, Krešimir ; Kenđel Jovanović, Gordana ; Dražić, Ivan ; Belančić, Andrej ; Skočibušić, Nataša ; Palčevski, Dora ; Rubinić, Igor et al. Analysis of the Gut Microbiome and Dietary Habits in Metastatic Melanoma Patients with a Complete and Sustained Response to Immunotherapy // Cancers, 15 (2023), 11; 103390, 17. doi: 10.3390/cancers15113052
Dedic Plavetic, Natalija ; Čular, Katarina ; Križić, Marija ; Popovic, Marina ; Plestina, Stjepko ; Silovski, Tajana Clinical characteristics and outcome of PIK3CA mutated hormone receptor positive (HR+), human epidermal growth factor 2 negative (HER2-), advanced breast cancer (BC) treated with cyclin- dependent kinase 4/6 inhibitors (CDK4/6i): Real world data. // Journal of clinical oncology. 2023. doi: 10.1200/JCO.2023.41.16_suppl.e13078
Lešnjaković, Lucija ; Ganoci, Lana ; Bilić, Ivan ; Šimičević, Livija ; Mucalo, Iva ; Pleština, Stjepko ; Božina, Nada DPYD genotyping and predicting fluoropyrimidine toxicity: where do we stand? // Pharmacogenomics, 24 (2023), 0135, 14. doi: 10.2217/pgs-2022-0135
Prejac, Juraj ; Kekez, Domina ; Belev, Borislav ; Prejac, Marija ; Pleština, Stjepko Frequency of Body Weight Loss is an Independent Prognostic Factor of First-Line Treatment Outcomes in Metastatic Colorectal Cancer // Nutrition and cancer, 74 (2022), 2; 520-526. doi: 10.1080/01635581.2021.1900300
Gojević, Ante ; Knežević Stromar, Ivana ; Orešković, Ivana ; Premužić, Marina ; Čuković Čavka, Silvija ; Sirotković-Skerlev, Maja ; Dedić Plavetić, Natalija ; Sedlić, Filip ; Vranić, Melita ; Ostojić, Rajko et al. Interleukin-17 as a Marker of Inflammation and Fibrosis in Liver. 2022. str. 19-19
Kulić, Ana ; Gojević, Ante ; Knežević Stromar, Ivana ; Orešković, Ivana ; Premužić, Marina ; Čuković Čavka, Silvija ; Sirotković-Skerlev, Maja ; Dedić Plavetić, Natalija ; Sedlić, Filip ; Vranić, Melita et al. Anti-p53 protutijela u bolestima jetre // Biochemia Medica. 2022. str. 163-163
Svaguša, Tomo ; Sikirić, Sunčana ; Milavić, Marija ; Šepac, Ana ; Seiwerth, Sven ; Miličić, Davor ; Gasparović, Hrvoje ; Biočina, Bojan ; Rudež, Igor ; Sutlić Željko et al. Mitochondrial Quality Control in Failing Human Hearts // 14. kongres Hrvatskog kardiološkog društva Zagreb, Hrvatska, 24.11.2022-27.11.2022
nije evidentirano
nije evidentirano